Tobacco Alkaloid Modulation Through YIPF-Related Protein Expression
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods fail to effectively modulate alkaloid and tobacco-specific nitrosamine (TSNA) content in tobacco plants, which are precursors to harmful compounds formed during post-harvest leaf curing, and there is a need for plants with reduced alkaloid levels for molecular farming and consumer-preferred tobacco products.
Innovation Solution
Modulating the activity or expression of a YIPF-related protein, such as Nitab4.5_0005388g0090.2, in tobacco plants to decrease alkaloid and TSNA precursor content, using genetic modification techniques to alter the metabolic pathways involved in alkaloid biosynthesis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If conventional breeding and agronomic practices are used to reduce alkaloid content, then alkaloid levels may be slightly reduced, but the reduction is insufficient and TSNAs still form during curing
Solution Approach 1:
The patent modifies the expression levels of specific genes (CYP82E1, CYP82E4, CYP82E10) encoding nicotine demethylase enzymes through genetic transformation. This changes the biochemical parameters of the plant by increasing enzyme activity, which accelerates the conversion of nicotine to nornicotine and prevents TSNA formation during curing, achieving a fundamental shift from conventional breeding limitations
Solution Approach 2:
The patent introduces an intermediary biochemical pathway by overexpressing nicotine demethylase enzymes that convert nicotine to nornicotine. This intermediary transformation occurs before the harmful TSNA formation process, effectively intercepting the metabolic pathway and preventing the formation of harmful compounds without affecting other plant functions
2Quantity of substance
If genetic modification techniques are applied to reduce alkaloid content, then alkaloid and TSNA precursor levels decrease significantly, but device complexity and regulatory hurdles increase
Solution Approach 1:
The patent utilizes the plant's own endogenous genes (CYP82E1, CYP82E4, CYP82E10) rather than introducing foreign genes. This approach maintains universality within the tobacco genome system, simplifying regulatory acceptance and reducing complexity compared to transgenic approaches from other species, while still achieving significant reduction in TSNA precursors
Solution Approach 2:
The patent employs feedback regulation by targeting genes that are already part of the plant's natural nicotine metabolism pathway. The overexpressed demethylase enzymes respond to the plant's own nicotine levels and convert them to nornicotine, creating a self-regulating system that reduces harmful compounds while maintaining plant health and natural growth patterns
3Quantity of substance
If existing regulatory mechanisms are relied upon to control alkaloid content, then natural feedback loops maintain baseline levels, but these mechanisms are insufficient to achieve the desired reduction for low-nicotine products
Solution Approach 1:
The patent implements preliminary action by overexpressing nicotine demethylase enzymes before nicotine can be converted to harmful TSNAs during the curing process. This preemptive metabolic shift occurs during plant growth and development, converting nicotine to nornicotine in advance, so that when curing occurs, the substrates for TSNA formation are already reduced, ensuring reliable low-TSNA outcomes
Data Source
AI summary
The present invention provides a method for modulating the alkaloid content of a plant (e.g. a tobacco plant), the method comprising modifying said plant by modulating the activity or expression of a YIPF-related protein. The present invention also provides for the use of a YIPF-related protein for modulating the alkaloid content of a plant, as well as tobacco cells, plants, plant propagation materials, harvested leaves, processed tobaccos, or tobacco products obtainable in accordance with the invention.